References analysis of the Wikipedia article "양성자 펌프 억제제" in the Korean version

doi.org

dx.doi.org

Azizollahi, Hamid Reza; Rafeey, Mandana (2016). “Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants”. 《Korean Journal of Pediatrics》 (대한소아과학회) 59 (5): 226–230. doi:10.3345/kjp.2016.59.5.226. PMC 4897158. PMID 27279887. 2020년 2월 5일에 확인함.

Sachs, G.; Shin, J. M.; Howden, C. W. (2006). “Review article: The clinical pharmacology of proton pump inhibitors”. 《Alimentary Pharmacology and Therapeutics》 23: 2–8. doi:10.1111/j.1365-2036.2006.02943.x. PMID 16700898.

Zajac P, Holbrook A, Super ME, Vogt M (March–April 2013). “An overview: Current clinical guidelines for the evaluation, diagnosis, treatment, and management of dyspepsia”. 《Osteopathic Family Physician》 5 (2): 79–85. doi:10.1016/j.osfp.2012.10.005.

Wang WH, Huang JQ, Zheng GF, Xia HH, Wong WM, Liu XG, 외. (February 2007). “Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials”. 《Clinical Gastroenterology and Hepatology》 5 (2): 178–85; quiz 140. doi:10.1016/j.cgh.2006.09.012. PMID 17174612.

Sachar H, Vaidya K, Laine L (November 2014). “Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis”. 《JAMA Internal Medicine》 174 (11): 1755–62. doi:10.1001/jamainternmed.2014.4056. PMC 4415726. PMID 25201154.

Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI, 외. (December 2013). “Optimum duration of regimens for Helicobacter pylori eradication”. 《The Cochrane Database of Systematic Reviews》 12 (12): CD008337. doi:10.1002/14651858.CD008337.pub2. PMID 24338763.

Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME (May 2013). “Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease”. 《The Cochrane Database of Systematic Reviews》 5 (5): CD002095. doi:10.1002/14651858.CD002095.pub5. PMC 7066537. PMID 23728637.

Chang AB, Lasserson TJ, Kiljander TO, Connor FL, Gaffney JT, Garske LA (January 2006). “Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux”. 《BMJ》 332 (7532): 11–7. doi:10.1136/bmj.38677.559005.55. PMC 1325125. PMID 16330475.

Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB (August 2014). “Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis”. 《Gut》 63 (8): 1229–37. doi:10.1136/gutjnl-2013-305997. PMC 4199831. PMID 24221456.

Lucendo AJ, Arias Á, Molina-Infante J (January 2016). “Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis”. 《Clinical Gastroenterology and Hepatology》 14 (1): 13–22.e1. doi:10.1016/j.cgh.2015.07.041. PMID 26247167.

Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ (March 2013). “Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis”. 《Critical Care Medicine》 41 (3): 693–705. doi:10.1097/CCM.0b013e3182758734. PMID 23318494. S2CID 8138473.

Epelboym I, Mazeh H (January 2014). “Zollinger-Ellison syndrome: classical considerations and current controversies”. 《The Oncologist》 19 (1): 44–50. doi:10.1634/theoncologist.2013-0369. PMC 3903066. PMID 24319020.

Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, 외. (October 2008). “American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease”. 《Gastroenterology》 135 (4): 1383–1391, 1391.e1–5. doi:10.1053/j.gastro.2008.08.045. PMID 18789939.

Xie Y, Bowe B, Yan Y, Xian H, Li T, Al-Aly Z (May 2019). “Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study”. 《BMJ》 (Washington University School of Medicine) 365: l1580. doi:10.1136/bmj.l1580. PMC 6538974. PMID 31147311. Taking PPIs is associated with a small excess of cause specific mortality including death due to cardiovascular disease, chronic kidney disease, and upper gastrointestinal cancer. The burden was also observed in patients without an indication for PPI use. 밴쿠버 양식 오류 (도움말)

Cooper BT, Chapman W, Neumann CS, Gearty JC (March 2006). “Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence”. 《Alimentary Pharmacology & Therapeutics》 23 (6): 727–33. doi:10.1111/j.1365-2036.2006.02825.x. PMID 16556174. S2CID 6969621.

Wilson, Janet A.; Stocken, Deborah D.; Watson, Gillian C.; Fouweather, Tony; McGlashan, Julian; MacKenzie, Kenneth; Carding, Paul; Karagama, Yakubu; Harries, Meredydd; Ball, Stephen; Khwaja, Sadie (2021년 1월 22일). “Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT”. 《Health Technology Assessment》 (영어) 25 (3): 1–118. doi:10.3310/hta25030. ISSN 2046-4924.

“Canadian Cardiovascular Society and Choosing Wisely Canada: The Road to Creating a List of Five Things Physicians and Patients Should Question”. 《Canadian Journal of Cardiology》 30 (8): 949–955. August 2014. doi:10.1016/j.cjca.2014.06.010. ISSN 0828-282X.

Hatlebakk JG, Katz PO, Camacho-Lobato L, Castell DO (October 2000). “Proton pump inhibitors: better acid suppression when taken before a meal than without a meal”. 《Alimentary Pharmacology & Therapeutics》 14 (10): 1267–72. doi:10.1046/j.1365-2036.2000.00829.x. PMID 11012470. S2CID 36206292.

Shin, Jai Moo; Sachs, George (December 2008). “Pharmacology of proton pump inhibitors”. 《Current Gastroenterology Reports》 (영어) 10 (6): 528–534. doi:10.1007/s11894-008-0098-4. ISSN 1522-8037.

Shin JM, Munson K, Vagin O, Sachs G (January 2009). “The gastric HK-ATPase: structure, function, and inhibition”. 《Pflügers Archiv》 457 (3): 609–22. doi:10.1007/s00424-008-0495-4. PMC 3079481. PMID 18536934.

Strand, Daniel S.; Kim, Daejin; Peura, David A. (2017년 1월 15일). “25 Years of Proton Pump Inhibitors: A Comprehensive Review”. 《Gut and Liver》 11 (1): 27–37. doi:10.5009/gnl15502. PMC 5221858. PMID 27840364.

nih.gov

ncbi.nlm.nih.gov

Dean, Laura (2010년 10월 1일). 《Comparing Proton Pump Inhibitors》. 《PubMed Health》 (National Center for Biotechnology Information (US)). 2016년 7월 16일에 확인함.

Qadeer MA, Phillips CO, Lopez AR, Steward DL, Noordzij JP, Wo JM, 외. (November 2006). “Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials”. 《The American Journal of Gastroenterology》 101 (11): 2646–54. PMID 17037995.

Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, 외. (May 2017). “Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline”. 《Canadian Family Physician》 63 (5): 354–364. PMC 5429051. PMID 28500192.

nihr.ac.uk

evidence.nihr.ac.uk

“PPIs should not be prescribed for throat symptoms”. 《NIHR Evidence》 (영국 영어). 2022년 1월 13일. 2022년 7월 6일에 확인함.

journalslibrary.nihr.ac.uk

semanticscholar.org

api.semanticscholar.org

worldcat.org

“[99] Comparative effectiveness of proton pump inhibitors”. 《Therapeutics Letter》. 2016년 6월 28일. ISSN 2369-8691. 2016년 7월 14일에 확인함.

wustl.edu

medicine.wustl.edu

양성자 펌프 억제제 (Korean Wikipedia)

choosingwisely.org

doi.org

dx.doi.org

fda.gov

handle.net

hdl.handle.net

kjg.or.kr

nih.gov

ncbi.nlm.nih.gov

nihr.ac.uk

evidence.nihr.ac.uk

journalslibrary.nihr.ac.uk

semanticscholar.org

api.semanticscholar.org

springer.com

link.springer.com

ubc.ca

ti.ubc.ca

web.archive.org

worldcat.org

wustl.edu

medicine.wustl.edu